Invitrogen Hit With Suit Over Semiconductor Patents

Law360, New York (September 22, 2008, 12:00 AM EDT) -- A bioscience company that has a licensing agreement with Evident Technologies Inc., which is battling a patent lawsuit by Invitrogen Corp., has filed suit against Invitrogen, seeking a ruling that its own products do not infringe Invitrogen's patent for nanocrystal semiconductors.

San Diego-based eBioscience Corp. filed the declaratory judgment suit Monday in the U.S. District Court for the Southern District of California.

According to the suit, eBioscience and Evident entered into a licensing agreement related to “quantum dot” technology, a type of semiconductor used to make...
To view the full article, register now.